UT System Sponsors Houston Molecular Medicine Symposium

Today's molecular medicine promises the ability to dramatically improve human health. New technologies have the potential to:

Predict an individual's susceptibility to disease.
Detect diseases at earlier (and more treatable times).
Tailor treatment to minimize complications.

Scientists, trainees and research staff members are invited to participate in a University of Texas System research symposium on molecular medicine Feb. 21 and 22 in Houston.

Sessions will focus on:

. Genetics, chaired by Margaret Spitz, M.D., UT M. D. Anderson Cancer Center; Dianna Milewicz, M.D., Ph.D., UT Health Science Center at Houston; and Sunil Ahuja, M.D., UT Health Science Center at San Antonio.

. Functional genomics, chaired by Stephen Johnston, Ph.D., UT Southwestern Medical Center at Dallas, and Allan Brasier, M.D., UT Medical Branch at Galveston (UTMB).

. Molecular imaging, chaired by Juri Gelovani, M.D., Ph.D., M. D. Anderson, and Fred Bonte, M.D., Southwestern.

. Molecular therapeutics, chaired by Gordon Mills, M.D., Ph.D., M. D. Anderson; Brent Iverson, Ph.D., UT Austin; and Larry Stanberry, M.D., UTMB.

Peter J. Davies, M.D., Ph.D., executive vice president for research at the UT Health Science Center at Houston, is a member of the planning committee. The cost will be $75, with online registration at http://www.utsystem.edu/hea/molecular/. For more information and a PowerPoint presentation, see http://research.uth.tmc.edu/events.html#mm.